# Tissue Characterization With Hyperspectral Imaging (HSI)

> **NCT04230603** · NA · UNKNOWN · sponsor: **University of Leipzig** · enrollment: 1000 (estimated)

## Conditions studied

- Tissue Perfusion
- Tumor
- Inflammation
- Inflammatory Bowel Diseases

## Interventions

- **PROCEDURE:** Hyperspectral imaging
- **DIAGNOSTIC_TEST:** Lactate acid measurement
- **DIAGNOSTIC_TEST:** pathological examination

## Key facts

- **NCT ID:** NCT04230603
- **Lead sponsor:** University of Leipzig
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-06
- **Primary completion:** 2022-01-02
- **Final completion:** 2022-06-02
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2020-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04230603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04230603, "Tissue Characterization With Hyperspectral Imaging (HSI)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04230603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*